OCM
MRNA icon

One Capital Management’s Moderna MRNA Stock Holding History

One Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,602
Closed -$309K – 389
2024
Q2 		$309K Buy
2,602
+60
+2% +$7.59K 0.01% 328
2024
Q1 		$271K Sell
2,542
-441
-15% -$44.5K 0.01% 264
2023
Q4 		$297K Sell
2,983
-827
-22% -$69.6K 0.01% 248
2023
Q3 		$394K Sell
3,810
-1,104
-22% -$123K 0.02% 210
2023
Q2 		$597K Buy
4,914
+140
+3% +$18.7K 0.03% 199
2023
Q1 		$733K Sell
4,774
-1,369
-22% -$226K 0.04% 188
2022
Q4 		$1.1M Sell
6,143
-721
-11% -$118K 0.06% 166
2022
Q3 		$811K Buy
6,864
+139
+2% +$21.1K 0.05% 178
2022
Q2 		$960K Sell
6,725
-920
-12% -$132K 0.06% 170
2022
Q1 		$1.32M Sell
7,645
-482
-6% -$81.1K 0.07% 158
2021
Q4 		$2.06M Buy
+8,127
New +$2.38M 0.16% 101

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

One Capital Management's MRNA Position: Q3 2024 in Review

One Capital Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,602 shares — an estimated $309K sold.

One Capital Management first reported a position in MRNA in Q4 2021 and held it in 11 quarters. The position peaked at $2.06M in Q4 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • One Capital Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • One Capital Management sold 2,602 Moderna shares in Q3 2024, an estimated $309K.
  • One Capital Management first reported a position in Moderna in Q4 2021 and held it in 11 quarters.
  • One Capital Management's Moderna position peaked at $2.06M in Q4 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on One Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.